PepGen Stock (NASDAQ: PEPG) stock price, news, charts, stock research, profile.
Open | $12.120 |
Close | $11.500 |
Volume / Avg. | 80.987K / 132.717K |
Day Range | 11.200 - 12.505 |
52 Wk Range | 3.720 - 17.510 |
Market Cap | $387.283M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 2.37% |
Days to Cover | 7.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PepGen (NASDAQ: PEPG) through any online brokerage.
Other companies in PepGen’s space includes: Skye Bioscience (NASDAQ:SKYE), Humacyte (NASDAQ:HUMA), Voyager Therapeutics (NASDAQ:VYGR), Replimune Group (NASDAQ:REPL) and CareDx (NASDAQ:CDNA).
The latest price target for PepGen (NASDAQ: PEPG) was reported by Wedbush on Thursday, March 7, 2024. The analyst firm set a price target for 20.00 expecting PEPG to rise to within 12 months (a possible 67.08% upside). 8 analyst firms have reported ratings in the last year.
The stock price for PepGen (NASDAQ: PEPG) is $11.97 last updated April 16, 2024 at 4:52 PM EDT.
There are no upcoming dividends for PepGen.
PepGen’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for PepGen.
PepGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.